Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A David Rodrigues

Showing results (91-100 of 132) with videos related to

Pageof 14
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 25, 2004
Validation of (-)-N-3-benzyl-phenobarbital as a selective inhibitor of CYP2C19 in human liver microsomesXiaoxin Cai, Regina W Wang, Richard W Edom, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 24, 2021
Quantitative prediction of breast cancer resistant protein mediated drug-drug interactions using physiologically-based pharmacokinetic modelingChester Costales, Jian Lin, Emi Kimoto, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 9, 2018
Simultaneous Assessment of Transporter-Mediated Drug-Drug Interactions Using a Probe Drug Cocktail in Cynomolgus MonkeyRachel E Kosa, Sarah Lazzaro, Yi-An Bi, et al.
British Journal of Clinical Pharmacology|December 24, 2010
Repaglinide-gemfibrozil drug interaction: inhibition of repaglinide glucuronidation as a potential additional contributing mechanismJinping Gan, Weiqi Chen, Hong Shen, et al.
Journal of Clinical Pharmacology|May 20, 2005
The effect of ketoconazole on the pharmacokinetics of a selective alpha 1A-adrenoceptor antagonistGregory A Winchell, Goutam C Mistry, Prasad P Kari, et al.
British Journal of Clinical Pharmacology|October 20, 2018
Plasma extracellular nanovesicle (exosome)-derived biomarkers for drug metabolism pathways: a novel approach to characterize variability in drug exposureAndrew Rowland, Warit Ruanglertboon, Madelé van Dyk, et al.
Chemical Research in Toxicology|September 19, 2019
Moving beyond Binary Predictions of Human Drug-Induced Liver Injury (DILI) toward Contrasting Relative Risk PotentialMichael D Aleo, Falgun Shah, Scott Allen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 26, 2012
Development of a carbon-14 labeling approach to support disposition studies with a pegylated biologicHaiqing Wang, Lifei Wang, Kai Cao, et al.
Clinical Pharmacology and Therapeutics|March 28, 2022
Evaluation of the Effect of Abrocitinib on Drug Transporters by Integrated Use of Probe Drugs and Endogenous BiomarkersManoli Vourvahis, Wonkyung Byon, Cheng Chang, et al.
Molecular Pharmaceutics|May 3, 2023
Characterization of Bile Acid Sulfate Conjugates as Substrates of Human Organic Anion Transporting PolypeptidesChristine C Orozco, Mikko Neuvonen, Yi-An Bi, et al.
Pageof 14

Showing results (91-100 of 132) with videos related to

Sort By:
Pageof 14
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 25, 2004
Validation of (-)-N-3-benzyl-phenobarbital as a selective inhibitor of CYP2C19 in human liver microsomesXiaoxin Cai, Regina W Wang, Richard W Edom, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 24, 2021
Quantitative prediction of breast cancer resistant protein mediated drug-drug interactions using physiologically-based pharmacokinetic modelingChester Costales, Jian Lin, Emi Kimoto, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 9, 2018
Simultaneous Assessment of Transporter-Mediated Drug-Drug Interactions Using a Probe Drug Cocktail in Cynomolgus MonkeyRachel E Kosa, Sarah Lazzaro, Yi-An Bi, et al.
British Journal of Clinical Pharmacology|December 24, 2010
Repaglinide-gemfibrozil drug interaction: inhibition of repaglinide glucuronidation as a potential additional contributing mechanismJinping Gan, Weiqi Chen, Hong Shen, et al.
Journal of Clinical Pharmacology|May 20, 2005
The effect of ketoconazole on the pharmacokinetics of a selective alpha 1A-adrenoceptor antagonistGregory A Winchell, Goutam C Mistry, Prasad P Kari, et al.
British Journal of Clinical Pharmacology|October 20, 2018
Plasma extracellular nanovesicle (exosome)-derived biomarkers for drug metabolism pathways: a novel approach to characterize variability in drug exposureAndrew Rowland, Warit Ruanglertboon, Madelé van Dyk, et al.
Chemical Research in Toxicology|September 19, 2019
Moving beyond Binary Predictions of Human Drug-Induced Liver Injury (DILI) toward Contrasting Relative Risk PotentialMichael D Aleo, Falgun Shah, Scott Allen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 26, 2012
Development of a carbon-14 labeling approach to support disposition studies with a pegylated biologicHaiqing Wang, Lifei Wang, Kai Cao, et al.
Clinical Pharmacology and Therapeutics|March 28, 2022
Evaluation of the Effect of Abrocitinib on Drug Transporters by Integrated Use of Probe Drugs and Endogenous BiomarkersManoli Vourvahis, Wonkyung Byon, Cheng Chang, et al.
Molecular Pharmaceutics|May 3, 2023
Characterization of Bile Acid Sulfate Conjugates as Substrates of Human Organic Anion Transporting PolypeptidesChristine C Orozco, Mikko Neuvonen, Yi-An Bi, et al.
Pageof 14